1130799

Jeremy Goverman, M.D. — FEI 3017177569

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 28, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)